Statistics for Riscos e benefícios dos anti-inflamatórios não esteróides inibidores seletivos da ciclo-oxigenase 2
Total visits
| views | |
|---|---|
| Riscos e benefícios dos anti-inflamatórios não esteróides inibidores seletivos da ciclo-oxigenase 2 | 2006 |
Total visits per month
| views | |
|---|---|
| July 2025 | 2 |
| August 2025 | 1 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| PPG_TaniaTavares.pdf | 46812 |
| PPG_19717.pdf | 3 |
| ProjetoFinal_23781.pdf | 2 |
| Anexo_3.docx | 2 |
| PPG_21481.pdf | 2 |
| PPG_19606.pdf | 2 |
| T_12882.pdf | 2 |
| DM_Jódna Lopes.pdf | 1 |
| PG_21283.pdf | 1 |
| PPG_23493.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 725 |
| Brazil | 677 |
| Portugal | 214 |
| Poland | 87 |
| China | 33 |
| Canada | 27 |
| Belgium | 26 |
| United Kingdom | 26 |
| France | 14 |
| Mexico | 13 |
| Germany | 11 |
| Angola | 8 |
| Netherlands | 7 |
| Russia | 7 |
| Mozambique | 6 |
| Italy | 5 |
| Iran | 3 |
| Panama | 3 |
| Paraguay | 3 |
| Australia | 2 |
| Colombia | 2 |
| Ukraine | 2 |
| A2 | 1 |
| Argentina | 1 |
| European Union | 1 |
| Greece | 1 |
| Hong Kong SAR China | 1 |
| Ireland | 1 |
| Japan | 1 |
| Mongolia | 1 |
| Namibia | 1 |
| Singapore | 1 |
| Thailand | 1 |
Top city views
| views | |
|---|---|
| Almada | 1 |
| Salvador | 1 |